COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,720 Articles (22,502 medRxiv, 8,218 bioRxiv)

Most recent first Previous |  Page 114: Articles 1131-1140  | Next

A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and combines a direct antiviral effect with subtle boosting of interferon
Van Loy, B., Pujol, E., Kamata, K., Lee, X. Y., Bakirtzoglou, N., Van Berwaer, R., Vandeput, J., Persoons, L., De Wijngaert, B., Goovaerts, Q., Noppen, S., Ahmadzadeh, K., Martin-Lopez, J., Escriche, C., Vanmechelen, B., Krasniqi, B., Singh, A. K., Maes, P., Matthys, P., Dehaen, W., Rozenski, J., Das, K., Voet, A., Vazquez, S., Naesens, L. M., Stevaert, A.
10.1101/2024.09.09.611961 — Posted: 2024-09-09
Forecasting COVID-19, Influenza and RSV hospitalisations over winter 2023/24 in England
Mellor, J., Tang, M. L., Jones, O., Infectious Disease Modelling Team, , Ward, T., Riley, S., Deeny, S. R.
10.1101/2024.09.07.24313175 — Posted: 2024-09-08
Correlates of COVID-19 conspiracy theory beliefs in Japan: A nationally-representative cross-sectional survey
Sato, Y., Kawachi, I., Saijo, Y., Yoshioka, E., Osaka, K., Tabuchi, T.
10.1101/2024.09.06.24313228 — Posted: 2024-09-07
Impact of vaccination on SARS-CoV-2 transmission in the UK: a modelling study
Derqui, N., Mishra, S., Hinsley, W. R., Bhatt, S., Laydon, D. J.
10.1101/2024.09.06.24313210 — Posted: 2024-09-07
Evaluating the Risk of Cardiovascular Adverse Events and Appendicitis After COVID-19 Diagnosis in Adults in the United States: Implications of the Start of Follow-Up
Layton, J. B., Lindaas, A., Muthuri, S. G., Lloyd, P. C., Richey, M. M., Gruber, J. F., Lyu, H., McKillop, M. M., Kowarski, L. S., Bui, C., Fisher, S. S., Clarke, T. C., Cheng, A. S., Wan, Z., Duenas, P. F., Chen, Y., Burrell, T., Sheng, M., Shoaibi, A., Chillarige, Y., Beers, J., Anthony, M. S., Forshee, R. A., Anderson, S. A.
10.1101/2024.09.05.24313134 — Posted: 2024-09-06
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Emberson, J. R., Thwaites, L., Campbell, M., Peto, L., Pessoa-Amorim, G., Staplin, N., Hamers, R. L., Amuasi, J., Nel, J., Kestelyn, E., Phong, N. T., Shrestha, A., Nasronudin, N., Sarkar, R., Thach, P. N., Patel, D., Samardi, U., Stewart, R., Nelwan, E., Rawal, M., Baillie, J. K., Buch, M. H., Day, J. N., Faust, S. N., Jaki, T., Jeffery, K., Juszczak, E., Knight, M., Lim, W. S., Mafham, M., Montgomery, A., Mumford, A., Rowan, K., Basnyat, B., Haynes, R., Landray, M. J.
10.1101/2024.09.04.24312992 — Posted: 2024-09-06
Religion and COVID 19 Pandemic for better or for worse?
Ranasinghe, S. U. U., Ranasinghe, L. I., Pathiraja, I.
10.1101/2024.09.04.24312776 — Posted: 2024-09-06
Inpatient Hospitalizations for COVID-19 Among Patients with Prader-Willi Syndrome: a National Inpatient Sample Analysis
Luccarelli, J., Strong, T. V., Rubin, E. B., McCoy, T. H.
10.1101/2024.09.06.24313191 — Posted: 2024-09-06
A multicenter study to assess the performance of the point-of-care RT-PCR Cobas SARS-CoV-2 & Influenza A/B nucleic acid test for use on the Cobas Liat system in comparison with centralized assays across healthcare facilities in the United States
Robbins, E. M., Bertuzis, R., Chiu, H.-C., Miller, L., Noutsios, C.
10.1101/2024.09.06.24313202 — Posted: 2024-09-06
Divergent inflammatory and neurology-related plasma protein profiles in individuals with long COVID following primary and breakthrough SARS-CoV-2 infections.
Bansal, A., Olechnowicz, S. W. Z., Kiernan-Walker, N., Cumming, J., Mazhari, R., COVID PROFILE consortium, , Cox, R. J., Mueller, I., Bowden, R., Eriksson, E. M.
10.1101/2024.09.06.24312838 — Posted: 2024-09-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).